(2S)-7-amino-2-[[(2S)-2-[[(10S,13S,16S,19R,22S,25S,26R)-22-[(2S)-butan-2-yl]-13-[3-(diaminomethylideneamino)propyl]-12,15,18,21,24-pentaoxo-25-[[(2R)-5-oxopyrrolidine-2-carbonyl]amino]-19,26-di(propan-2-yl)-3,5,7,11,14,17,20,23-octazapentacyclo[14.13.2.12,27.15,8.04,30]tritriaconta-1,4(30),6,8(33),27(32),28-hexaene-10-carbonyl]amino]-2-(1H-imidazol-5-yl)acetyl]amino]heptanoic acid
Internal ID | 1a9cea87-8195-42f6-a01c-412e1cb17a9b |
Taxonomy | Organic acids and derivatives > Carboxylic acids and derivatives > Amino acids, peptides, and analogues > Peptides > Cyclic peptides |
IUPAC Name | (2S)-7-amino-2-[[(2S)-2-[[(10S,13S,16S,19R,22S,25S,26R)-22-[(2S)-butan-2-yl]-13-[3-(diaminomethylideneamino)propyl]-12,15,18,21,24-pentaoxo-25-[[(2R)-5-oxopyrrolidine-2-carbonyl]amino]-19,26-di(propan-2-yl)-3,5,7,11,14,17,20,23-octazapentacyclo[14.13.2.12,27.15,8.04,30]tritriaconta-1,4(30),6,8(33),27(32),28-hexaene-10-carbonyl]amino]-2-(1H-imidazol-5-yl)acetyl]amino]heptanoic acid |
SMILES (Canonical) | CCC(C)C1C(=O)NC(C(=O)NC2CC3=C(NC4=C3C=CC(=C4)C(C(C(=O)N1)NC(=O)C5CCC(=O)N5)C(C)C)N6C=C(CC(NC(=O)C(NC2=O)CCCN=C(N)N)C(=O)NC(C7=CN=CN7)C(=O)NC(CCCCCN)C(=O)O)N=C6)C(C)C |
SMILES (Isomeric) | CC[C@H](C)[C@H]1C(=O)N[C@@H](C(=O)N[C@H]2CC3=C(NC4=C3C=CC(=C4)[C@H]([C@@H](C(=O)N1)NC(=O)[C@H]5CCC(=O)N5)C(C)C)N6C=C(C[C@H](NC(=O)[C@@H](NC2=O)CCCN=C(N)N)C(=O)N[C@@H](C7=CN=CN7)C(=O)N[C@@H](CCCCCN)C(=O)O)N=C6)C(C)C |
InChI | InChI=1S/C57H82N18O11/c1-7-29(6)44-53(82)71-43(28(4)5)52(81)70-39-22-33-32-15-14-30(42(27(2)3)46(55(84)72-44)74-49(78)35-16-17-41(76)65-35)20-37(32)66-47(33)75-24-31(64-26-75)21-38(69-48(77)34(67-50(39)79)13-11-19-62-57(59)60)51(80)73-45(40-23-61-25-63-40)54(83)68-36(56(85)86)12-9-8-10-18-58/h14-15,20,23-29,34-36,38-39,42-46,66H,7-13,16-19,21-22,58H2,1-6H3,(H,61,63)(H,65,76)(H,67,79)(H,68,83)(H,69,77)(H,70,81)(H,71,82)(H,72,84)(H,73,80)(H,74,78)(H,85,86)(H4,59,60,62)/t29-,34-,35+,36-,38-,39-,42+,43+,44-,45-,46-/m0/s1 |
InChI Key | FHWIRTXPSAFRCL-ZYCUMPKISA-N |
Popularity | 0 references in papers |
Molecular Formula | C57H82N18O11 |
Molecular Weight | 1195.40 g/mol |
Exact Mass | 1194.64104550 g/mol |
Topological Polar Surface Area (TPSA) | 452.00 Ų |
XlogP | -2.10 |
Atomic LogP (AlogP) | -1.18 |
H-Bond Acceptor | 15 |
H-Bond Donor | 15 |
Rotatable Bonds | 21 |
There are no found synonyms. |
![2D Structure of (2S)-7-amino-2-[[(2S)-2-[[(10S,13S,16S,19R,22S,25S,26R)-22-[(2S)-butan-2-yl]-13-[3-(diaminomethylideneamino)propyl]-12,15,18,21,24-pentaoxo-25-[[(2R)-5-oxopyrrolidine-2-carbonyl]amino]-19,26-di(propan-2-yl)-3,5,7,11,14,17,20,23-octazapentacyclo[14.13.2.12,27.15,8.04,30]tritriaconta-1,4(30),6,8(33),27(32),28-hexaene-10-carbonyl]amino]-2-(1H-imidazol-5-yl)acetyl]amino]heptanoic acid 2D Structure of (2S)-7-amino-2-[[(2S)-2-[[(10S,13S,16S,19R,22S,25S,26R)-22-[(2S)-butan-2-yl]-13-[3-(diaminomethylideneamino)propyl]-12,15,18,21,24-pentaoxo-25-[[(2R)-5-oxopyrrolidine-2-carbonyl]amino]-19,26-di(propan-2-yl)-3,5,7,11,14,17,20,23-octazapentacyclo[14.13.2.12,27.15,8.04,30]tritriaconta-1,4(30),6,8(33),27(32),28-hexaene-10-carbonyl]amino]-2-(1H-imidazol-5-yl)acetyl]amino]heptanoic acid](https://plantaedb.com/storage/docs/compounds/2023/11/b94b4170-824b-11ee-a6a8-21771fc845e8.jpg)
Target | Value | Probability (raw) | Probability (%) |
---|---|---|---|
Human Intestinal Absorption | + | 0.9097 | 90.97% |
Caco-2 | - | 0.8664 | 86.64% |
Blood Brain Barrier | - | 0.6250 | 62.50% |
Human oral bioavailability | - | 0.6714 | 67.14% |
Subcellular localzation | Mitochondria | 0.3878 | 38.78% |
OATP2B1 inhibitior | - | 0.8566 | 85.66% |
OATP1B1 inhibitior | + | 0.8055 | 80.55% |
OATP1B3 inhibitior | + | 0.9382 | 93.82% |
MATE1 inhibitior | - | 0.7409 | 74.09% |
OCT2 inhibitior | - | 0.6500 | 65.00% |
BSEP inhibitior | + | 0.9660 | 96.60% |
P-glycoprotein inhibitior | + | 0.7436 | 74.36% |
P-glycoprotein substrate | + | 0.8704 | 87.04% |
CYP3A4 substrate | + | 0.7473 | 74.73% |
CYP2C9 substrate | - | 0.8030 | 80.30% |
CYP2D6 substrate | - | 0.8391 | 83.91% |
CYP3A4 inhibition | - | 0.9594 | 95.94% |
CYP2C9 inhibition | - | 0.8411 | 84.11% |
CYP2C19 inhibition | - | 0.8217 | 82.17% |
CYP2D6 inhibition | - | 0.8989 | 89.89% |
CYP1A2 inhibition | - | 0.8213 | 82.13% |
CYP2C8 inhibition | + | 0.8531 | 85.31% |
CYP inhibitory promiscuity | - | 0.9572 | 95.72% |
UGT catelyzed | - | 0.0000 | 0.00% |
Carcinogenicity (binary) | - | 0.8900 | 89.00% |
Carcinogenicity (trinary) | Non-required | 0.6121 | 61.21% |
Eye corrosion | - | 0.9853 | 98.53% |
Eye irritation | - | 0.8967 | 89.67% |
Skin irritation | - | 0.7699 | 76.99% |
Skin corrosion | - | 0.9293 | 92.93% |
Ames mutagenesis | - | 0.6500 | 65.00% |
Human Ether-a-go-go-Related Gene inhibition | + | 0.6672 | 66.72% |
Micronuclear | + | 0.9100 | 91.00% |
Hepatotoxicity | + | 0.6375 | 63.75% |
skin sensitisation | - | 0.8463 | 84.63% |
Respiratory toxicity | + | 0.7556 | 75.56% |
Reproductive toxicity | + | 0.9222 | 92.22% |
Mitochondrial toxicity | + | 0.8875 | 88.75% |
Nephrotoxicity | - | 0.7121 | 71.21% |
Acute Oral Toxicity (c) | III | 0.5332 | 53.32% |
Estrogen receptor binding | + | 0.6470 | 64.70% |
Androgen receptor binding | + | 0.7438 | 74.38% |
Thyroid receptor binding | + | 0.7029 | 70.29% |
Glucocorticoid receptor binding | + | 0.7230 | 72.30% |
Aromatase binding | + | 0.7578 | 75.78% |
PPAR gamma | + | 0.7505 | 75.05% |
Honey bee toxicity | - | 0.6524 | 65.24% |
Biodegradation | - | 0.8750 | 87.50% |
Crustacea aquatic toxicity | + | 0.6000 | 60.00% |
Fish aquatic toxicity | + | 0.9076 | 90.76% |
Proven Targets:
CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
---|---|---|---|---|---|
No proven targets yet! |
Predicted Targets (via Super-PRED):
CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
---|---|---|---|---|
CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 99.90% | 96.09% |
CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 99.74% | 94.45% |
CHEMBL4040 | P28482 | MAP kinase ERK2 | 99.67% | 83.82% |
CHEMBL2581 | P07339 | Cathepsin D | 99.44% | 98.95% |
CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 99.26% | 91.11% |
CHEMBL4462 | Q8IXJ6 | NAD-dependent deacetylase sirtuin 2 | 98.59% | 90.24% |
CHEMBL3137262 | O60341 | LSD1/CoREST complex | 97.53% | 97.09% |
CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 97.31% | 97.23% |
CHEMBL1937 | Q92769 | Histone deacetylase 2 | 97.25% | 94.75% |
CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 97.10% | 93.56% |
CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 97.00% | 90.08% |
CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 96.97% | 99.17% |
CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 96.26% | 95.89% |
CHEMBL2535 | P11166 | Glucose transporter | 95.84% | 98.75% |
CHEMBL3310 | Q96DB2 | Histone deacetylase 11 | 95.23% | 88.56% |
CHEMBL221 | P23219 | Cyclooxygenase-1 | 95.11% | 90.17% |
CHEMBL3038469 | P24941 | CDK2/Cyclin A | 94.98% | 91.38% |
CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 94.17% | 90.71% |
CHEMBL255 | P29275 | Adenosine A2b receptor | 93.44% | 98.59% |
CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 92.78% | 96.00% |
CHEMBL2243 | O00519 | Anandamide amidohydrolase | 91.41% | 97.53% |
CHEMBL325 | Q13547 | Histone deacetylase 1 | 91.01% | 95.92% |
CHEMBL213 | P08588 | Beta-1 adrenergic receptor | 90.83% | 95.56% |
CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 90.08% | 98.33% |
CHEMBL3267 | P48736 | PI3-kinase p110-gamma subunit | 90.02% | 95.71% |
CHEMBL220 | P22303 | Acetylcholinesterase | 89.79% | 94.45% |
CHEMBL6136 | O60341 | Lysine-specific histone demethylase 1 | 89.66% | 95.58% |
CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 89.64% | 96.47% |
CHEMBL4227 | P25090 | Lipoxin A4 receptor | 89.47% | 100.00% |
CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 89.29% | 100.00% |
CHEMBL4506 | Q96EB6 | NAD-dependent deacetylase sirtuin 1 | 88.75% | 88.33% |
CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 87.78% | 95.56% |
CHEMBL3384 | Q16512 | Protein kinase N1 | 87.45% | 80.71% |
CHEMBL1293249 | Q13887 | Kruppel-like factor 5 | 87.26% | 86.33% |
CHEMBL4101 | P17612 | cAMP-dependent protein kinase alpha-catalytic subunit | 87.21% | 82.86% |
CHEMBL2815 | P04629 | Nerve growth factor receptor Trk-A | 87.14% | 87.16% |
CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 86.78% | 99.23% |
CHEMBL3837 | P07711 | Cathepsin L | 85.89% | 96.61% |
CHEMBL236 | P41143 | Delta opioid receptor | 85.85% | 99.35% |
CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 84.46% | 93.00% |
CHEMBL5028 | O14672 | ADAM10 | 84.39% | 97.50% |
CHEMBL1075162 | Q13304 | Uracil nucleotide/cysteinyl leukotriene receptor | 84.38% | 80.33% |
CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 84.13% | 97.64% |
CHEMBL1163125 | O60885 | Bromodomain-containing protein 4 | 84.11% | 97.31% |
CHEMBL1781 | P11387 | DNA topoisomerase I | 83.97% | 97.00% |
CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha | 83.41% | 85.14% |
CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 82.11% | 88.42% |
CHEMBL5896 | O75164 | Lysine-specific demethylase 4A | 81.67% | 99.09% |
CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 81.66% | 95.89% |
CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 81.50% | 89.00% |
CHEMBL3835 | P51955 | Serine/threonine-protein kinase NEK2 | 81.45% | 80.33% |
CHEMBL1907600 | Q00535 | Cyclin-dependent kinase 5/CDK5 activator 1 | 80.88% | 93.03% |
CHEMBL1744525 | P43490 | Nicotinamide phosphoribosyltransferase | 80.49% | 96.25% |
CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 80.23% | 94.66% |
CHEMBL5939 | Q9NZ08 | Endoplasmic reticulum aminopeptidase 1 | 80.21% | 100.00% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
Celosia argentea |
PubChem | 162924854 |
LOTUS | LTS0175662 |
wikiData | Q104995485 |